Andrea M. Henle, Ph.D. - Publications
Affiliations: | 2012 | Immunology | College of Medicine - Mayo Clinic |
Area:
Immunology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2018 | Perez DE, Henle AM, Amsterdam A, Hagen HR, Lees JA. Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology. Pigment Cell & Melanoma Research. PMID 29570931 DOI: 10.1111/Pcmr.12700 | 0.316 | |||
2017 | Henle AM, Nassar A, Puglisi-Knutson D, Youssef B, Knutson KL. Downregulation of TAP1 and TAP2 in early stage breast cancer. Plos One. 12: e0187323. PMID 29091951 DOI: 10.1371/Journal.Pone.0187323 | 0.45 | |||
2013 | Henle AM, Erskine CL, Benson LM, Clynes R, Knutson KL. Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells. Journal of Immunology (Baltimore, Md. : 1950). 190: 479-88. PMID 23180824 DOI: 10.4049/Jimmunol.1201264 | 0.46 | |||
2012 | Erskine CL, Henle AM, Knutson KL. Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence system Journal of Visualized Experiments : Jove. e3683. PMID 22895471 DOI: 10.3791/3683 | 0.405 | |||
Show low-probability matches. |